🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Silence Therapeutics plc

SLN Healthcare
$6.2 $-0.29 (-4.47%)
Market Cap: $292.85 M
Gurus Holding
1
Popularity Rank
#4722
% of Shares Held
0.25%
Net Activity (Q1 2026)
+$29,728.07

Guru Ownership Trend

Guru Analysis for Silence Therapeutics plc (SLN)

Silence Therapeutics plc (SLN), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $742,208.2.

Top institutional holders include Steven Cohen.

Institutional sentiment is currently Bullish. This is evidenced by a $29,728.07 net inflow during the quarter.

Recent activity highlights Steven Cohen who increased their stake by 5.0%.

Key Holders

Top 5 by Value

$630,877

Top 5 by Conviction

0.00%

Recent Activity Breakdown (Q1 2026)

+$29,728.07
Total Buy Value
New Buys 0
Additions 1
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
0
Net Buyers
1

FAQs for Silence Therapeutics plc (SLN)

Major holders include Steven Cohen ($630,877). According to the latest reported data, 1 tracked investment managers collectively hold approximately 119,711 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $29,728.07, with 1 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in SLN during the most recent reporting period.

Yes, 0 managers opened new positions in SLN, and 1 increased their existing holdings. The total reported buy value was $29,728.07.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 5.0% 119,711 $630,877 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form